Sulindac
NDC Package 68151-2872-0

11-digit billing NDC: 68151287200
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Sulindac is carefully consider the potential benefits and risks of sulindac and other treatment options before deciding to use sulindac. Marketed by Carilion Materials Management, this product is identified by NDC 68151-2872 and is authorized under FDA application ANDA071795.

Identification & Billing

NDC Package Code
68151-2872-0
Package Description
1 TABLET in 1 PACKAGE
Product Code
68151-2872
11-Digit Billing Format
68151287200
RxNorm Crosswalk
RxCUI: 198239 - sulindac 200 MG Oral Tablet

Clinical Specifications

Proprietary Name
Sulindac
Dosage Form
-
Usage Information
Carefully consider the potential benefits and risks of sulindac and other treatment options before deciding to use sulindac. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see ). WARNINGSSulindac tablets are indicated for acute long-term use in the relief of signs and symptoms of the following:OsteoarthritisRheumatoid arthritis*Ankylosing spondylitisAcute painful shoulder (Acute subacromial bursitis/supraspinatus tendinitis)Acute gouty arthritis * The safety and effectiveness of sulindac have not been established in rheumatoid arthritis patients who are designated in the American Rheumatism Association classification as Functional Class IV (incapacitated, largely or wholly bedridden, or confined to wheelchair; little or no self-care).

Regulatory & Marketing

Labeler Name
Carilion Materials Management
FDA Application #
ANDA071795
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-03-1990
Listing Expiration
12-31-2018
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68151-2872-0 identifies a specific commercial package of 1 tablet in 1 package of Sulindac, labeled by Carilion Materials Management. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Carilion Materials Management on April 03, 1990. The current certification is valid through December 31, 2018.

How is this Carilion Materials Management product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68151287200. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
68151-2872-0
11-Digit CMS (5-4-2)
68151-2872-00

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.